mGlu同型和异型分子的独特药理学
bioRxiv : the preprint server for biology
|November 28, 2024
概括
在响应选择性联结体时,甲基酸盐受体 (mGlu) 双元体表现出独特的信号配置. 这些发现表明mGlu受体的行为不受子单元相互作用的简单,可概括的规则的支配.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
- 分子生物学分子生物学
背景情况:
- 代代位性谷氨酸受体 (mGluRs) 是已知的G蛋白合受体,可以形成约束二次体.
- 虽然同体化是常见的,但异体化和其产生的药理学概况的特定组合在很大程度上仍未被描述.
研究的目的:
- 调查各种II和III组mGlu同位体和异位体的药理性质.
- 了解不同亚单元组合如何影响受体对选择性连接体的反应.
主要方法:
- 在HEK293T细胞中检查了随机组装的mGlu二极体.
- 采用了改进的G蛋白介导BRET测定与NanoLuciferase片段进行特定测量.
主要成果:
- 随机组装的二次元表现出不同的信号特征,其中一些有利于主导子单位,而另一些则显示混合配置文件.
- 对奥托斯特激动剂和全调节剂的反应在不同的mGlu二聚合物组合中有显著差异,包括含有mGlu2和III组子单元的组合.
- 在各种II组和III组mGlu二聚合物对中观察到谷氨酸和选择性激动剂的独特度-反应概况.
结论:
- mGlu受体二极体对选择性联结体表现出独特的反应.
- 在mGlu家族中的二维子单元相互作用的信号后果是复杂的,并且不受一般化的规则的约束.
相关概念视频
Cooperative Allosteric Transitions
7.9K
Cooperative allosteric transitions can occur in multimeric proteins, where each subunit of the protein has its own ligand-binding site. When a ligand binds to any of these subunits, it triggers a conformational change that affects the binding sites in the other subunits; this can change the affinity of the other sites for their respective ligands. The ability of the protein to change the shape of its binding site is attributed to the presence of a mix of flexible and stable segments in the...
7.9K
The Two-State Receptor Model
1.9K
The two-state receptor model explains a drug's interaction with receptors, such as G protein-coupled receptors and ligand-gated ion channels, to induce or inhibit a biological response. When no natural ligands are present, a receptor exists in an equilibrium of inactive (Ri) and active (Ra) conformations. The inactive form does not produce a response, while the active form generates a basal effect known as constitutive activity.
The binding affinity of a drug determines its interaction with...
The binding affinity of a drug determines its interaction with...
1.9K
Opioid Receptors: Overview
529
Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
529
Transducer Mechanism: G Protein–Coupled Receptors
1.8K
G Protein–Coupled Receptors (GPCRs) are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to various stimuli. GPCRs regulate critical physiological pathways and are excellent drug targets for treating diseases such as diabetes, cancer, obesity, depression, or Alzheimer's. Nearly 35% of approved drugs implement their therapeutic effects by selectively interacting with specific GPCRs.
GPCRs are also called heptahelical,...
GPCRs are also called heptahelical,...
1.8K
Activation and Inactivation of G Proteins
6.8K
Heterotrimeric G proteins are guanine nucleotide-binding proteins. As the name suggests, heterotrimeric G proteins are composed of three subunits: alpha, beta, and gamma. They remain GDP-bound or GTP-bound inside the cells and switch between inactive/active states. The Gα subunit possesses the nucleotide-binding pocket that binds guanine nucleotides and switches between GDP or GTP-bound states. In contrast, the Gꞵ and Gγ subunits are always bound together with high...
6.8K
Ligand-Gated Ion Channel Receptor: Gating Mechanism
2.1K
Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
2.1K


